|
1
|
Roberts JM: Pregnancy related
hypertension. Maternal Fetal Medicine. Creasy RK and Resnik R:
(4th). W.B Saunders. (Philadelphia, PA). 833–872. 1998.
|
|
2
|
Frampton GK, Jones J, Rose M and Payne L:
Placental growth factor (alone or in combination with soluble
fms-like tyrosine kinase 1) as an aid to the assessment of women
with suspected pre-eclampsia: Systematic review and economic
analysis. Health Technol Assess. 20:1–160. 2016. View Article : Google Scholar
|
|
3
|
Pasquali M, Serchi T, Planchon S and
Renaut J: 2D-DIGE in proteomics. Methods Mol Biol. 1654:245–254.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Alban A, David SO, Bjorkesten L, Andersson
C, Sloge E, Lewis S and Currie I: A novel experimental design for
comparative two-dimensional gel analysis: Two-dimensional
difference gel electrophoresis incorporating a pooled internal
standard. Proteomics. 3:36–44. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wei YS, Zheng YH, Liang WB, Zhang JZ, Yang
ZH, Lv ML, Jia J and Zhang L: Identification of serum biomarkers
for nasopharyngeal carcinoma by proteomic analysis. Cancer.
112:544–551. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vuadens F, Benay C, Crettaz D, Gallot D,
Sapin V, Schneider P, Bienvenut WV, Lémery D, Quadroni M, Dastugue
B and Tissot JD: Identification of biologic markers of the
premature rupture of fetal membranes: Proteomic approach.
Proteomics. 3:1521–1525. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Roberts JM, August PA, Bakris G, Barton
JR, Bernstein IM, Druzin M, Gaiser RR, Granger JP, Jeyabalan A,
Johnson DD, et al: American College of Obstetricians and
Gynecologists; Task Force on Hypertension in Pregnancy.
Hypertension in pregnancy. Report of the American College of
Obstetricians and Gynecologists' Task Force on Hypertension in
Pregnancy. Obstet Gynecol. 122:1122–1131. 2013.PubMed/NCBI
|
|
8
|
Anand S, Bench Alvarez TM, Johnson WE,
Esplin MS, Merrell K, Porter TF and Graves SW: Serum biomarkers
predictive of pre-eclampsia. Biomark Med. 9:563–575. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim SM, Cho BK, Kang MJ, Norwitz ER, Lee
SM, Lee J, Park CW, Kim BJ, Jun JK, Park JS and Yi EC: Expression
changes of proteins associated with the development of preeclampsia
in maternal plasma: A case-control study. Proteomics. 16:1581–1589.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kolialexi A, Mavreli D, Tounta G, Mavrou A
and Papantoniou N: Urine proteomic studies in preeclampsia.
Proteomics Clin Appl. 9:501–506. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Carty DM, Siwy J, Brennand JE, Zürbig P,
Mullen W, Franke J, McCulloch JW, Roberts CT, North RA, Chappell
LC, et al: Urinary proteomics for prediction of preeclampsia.
Hypertension. 57:561–569. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Buhimschi IA, Zhao G, Funai E, Saade GR
and Buhimschi C: Proteomics analysis of urine in preeclampsia (PE):
A novel diagnosis for an old disease. Am J Obstet Gynecol.
193:S152005. View Article : Google Scholar
|
|
13
|
Blankley RT, Gaskell SJ, Whetton AD, Dive
C, Baker PN and Myers JE: A proof-of-principle gel-free proteomics
strategy for the identification of predictive biomarkers for the
onset of pre-eclampsia. BJOG. 116:1473–1480. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Uehara Y, Makino H, Seiki K and Urade Y;
L-PGDS Clinical Research Group of Kidney, : Urinary excretions of
lipocalin-type prostaglandin D synthase predict renal injury in
type-2 diabetes: A cross-sectional and prospective multicentre
study. Nephrol Dial Transplant. 24:475–482. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gerhardt T, Pöge U, Stoffel-Wagner B,
Klein B, Klehr HU, Sauerbruch T and Woitas RP: Serum levels of
beta-trace protein and its association to diuresis in haemodialysis
patients. Nephrol Dial Transplant. 23:309–314. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bacci MR, Cavallari MR, de Rozier-Alves
RM, Alves Bda C and Fonseca FL: The impact of
lipocalin-type-prostaglandin-D-synthase as a predictor of kidney
disease in patients with type 2 diabetes. Drug Des Devel Ther.
22:3179–3182. 2015.
|
|
17
|
Saito S, Tsuda H and Michimata T:
Prostaglandin D2 and reproduction. Am J Reprod Immunol. 47:295–302.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gubbiotti MA, Neill T and Iozzo RV: A
current view of perlecan in physiology and pathology: A mosaic of
functions. Matrix Biol. 57-58:285–298. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Smith S and Hassell JR: Focus on
molecules: Perlecan (HSPG2). Exp Eye Res. 83:471–472. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Conde-Knape K: Heparan sulfate
proteoglycans in experimental models of diabetes: A role for
perlecan in diabetes complications. Diabetes Metab Res Rev.
17:412–421. 2001. View
Article : Google Scholar : PubMed/NCBI
|
